TNFSF11 and neoplasm: Additionally, tumor-activated platelets upregulate membrane-bound receptor activator of nuclear factor-κ B ligand (RANKL) isoforms that directly impair NK cell effector functions, an immunosuppressive phenotype partially reversible through RANKL inhibition [53].